Increasing alkali supplementation decreases urinary nitrogen excretion when adjusted for same day nitrogen intake

Abstract

We examined whether escalating doses of potassium bicarbonate (KHCO3) supplements alter urinary nitrogen excretion expressed as a ratio to same day nitrogen intake (measure of muscle-protein breakdown). The ratio declined significantly from placebo to low to high dose of KHCO3 supplementation in older adults over 3 months, suggesting muscle-sparing.

Introduction: Neutralization of dietary acid load with alkali supplementation (i.e., KHCO3) has been hypothesized to have muscle protein-sparing effects. In controlled feeding studies with fixed nitrogen (N) intake/day, 24-h urinary N excretion is a good marker of muscle breakdown. However, in studies with self-selected diets, changes in 24-h urinary N excretion can be influenced by shifts in N intake.

Methods: We evaluated changes in 24-h total urinary N excretion as a ratio of N excretion to concurrent N intake in 233 older men and women who participated in an 84-day KHCO3 supplementation randomized placebo-controlled trial.

Results: After adjustment for relevant cofactors, escalating doses of KHCO3 (1 mmol/kg/day [low] or 1.5 mmol/kg/day [high]) resulted in a progressive decline in urinary N excretion/N intake compared to placebo (overall P for trend = 0.042). The 84-day change in urinary N excretion/N intake in the high-dose KHCO3 group was statistically significantly lower compared to placebo (P = 0.012) but not compared to the low-dose KHCO3 group (P = 0.276). The 84-day change in urinary N excretion/N intake in the low-dose KHCO3 group did not differ significantly from placebo (P = 0.145).

Conclusions: Urinary N excretion expressed as ratio to same day N intake declined steadily with increasing doses of KHCO3 supplementation from low 1 mmol/kg/day to high 1.5 mmol/kg/day, suggesting a nitrogen-sparing effect. Compared to urinary N excretion alone, this ratio could be a more reasonable measure of muscle protein metabolism in large-scale long-term human studies.

Trial registration: Clinicaltrials.gov NCT1475214.

Trial registration: ClinicalTrials.gov NCT01475214.

Keywords: Alkali; Nitrogen excretion; Potassium bicarbonate; Skeletal muscle.

Conflict of interest statement

Disclosures

Lisa Ceglia and Bess Dawson-Hughes declare that they have no conflicts of interest.

Figures

Figure 1.

Adjusted means ± SE by treatment group of 84-day change in urinary N excretion/N intake by group. Adjustment made for baseline urinary N excretion/N intake, age, baseline weight, baseline lean body mass, baseline physical activity score, and baseline urinary NAE. *p=0.012 compared to placebo.